OR Foundation
  • About
    • Oral Reconstruction Foundation
      • Purpose and Mission
      • Foundation Board
      • Scientific Working Group
      • Education Working Group
      • History
      • Career
      • News
  • Granting
    • Requirements
    • Application
  • Publications
    • Grant Publications
    • Consensus Publications
  • Awards
    • Research Award
      • Awards 2018/2019
      • Award 2016/2017
      • Award 2014/2015
      • Award 2012/2013
      • Award 2010/2011
      • Award 2008/2009
    • Poster Competition
      • Competition 2018
      • Competition 2016
      • Competition 2014
      • Competition 2012
  • Education
    • International Symposia
    • Global Symposia
    • National Symposia
    • Curriculum
    • Education Courses
    • Webinars
  • Contact
Select Page

Prevalence of Peri-implant Diseases in Patients with Full-Arch Implant-Supported Restorations: A Systematic Review


Ramanauskaite A, Glarraga-Vinueza ME, Obreja K, Sader R, Schwarz F.

Int J Prosthodont. 2021 Suppl;34:s27-s45

Abstract

Objective:

To assess the prevalence of peri-implant diseases (ie, peri-implant mucositis and peri-implantitis) in patients rehabilitated with full-arch, implant-supported restorations.

Material and methods:

A search protocol was developed to answer the following focus question: What is the prevalence of peri-implant diseases in edentulous patients rehabilitated with implant-supported fixed or removable restorations? RCTs, controlled clinical trials, and prospective studies with at least 12 months of follow-up and a minimum of 10 patients having at least one edentulous arch were searched.

Results:

A total of 18 studies (3 RCTs, 1 nonrandomized controlled trial, and 14 prospective studies) were included. According to a single study, the prevalence of peri-implant mucositis in fully edentulous patients was 57%, corresponding to 47% at the implant level. The prevalence of peri-implant mucositis among patients having at least one edentulous arch ranged between 0% and 13.7% of patients, and from 0% to 20% of implants. In fully edentulous patients, the prevalence of peri-implantitis was found to range between 1.5% and 29.7% of patients and between 2.1% and 20.3% of the implants, while the corresponding values among the patients with at least one edentulous arch were 0% to 25% and 0% to 7.2%, respectively.

Conclusion:

Edentulous patients (fully edentulous or at least one edentulous arch) restored with either fixed or removable restorations were frequently affected by peri-implant disease.

SOURCE

Latest Research Award Winners

Dr. Yifan Zhang
Quantitative Clinical Adjustment Analysis of Posterior Single Implant Crown in a Chairside Digital Workflow: A Randomized Controlled Trial. Clin Oral Impl Res. 2019;30:1059-1066

Read more

Dr. Hyun-Chang Lim
Tissue integration of zirconia and titanium implants with and without buccal dehiscence defects — A histologic and radiographic preclinical study. Clin Oral Impl Res. 2019;30:660-9

Read more

Dr. Lorenzo Tavelli
Acellular dermal matrix and coronally advanced flap or tunnel technique in the treatment of multiple adjacent gingival recessions. A 12-year follow-up from a randomized clinical trial. J Clin Periodontol. 2019;46:937-48

Read more

Dr. Lukasz Witek
Repair of critical-sized long bone defects using dipyridamole-augmented 3D-printed bioactive ceramic scaffolds. J Orthop Res. 2019;37:2499-507

Read more

Oral Reconstruction Foundation


Margarethenstrasse 38 

4053 Basel
Switzerland

Phone: +41 61 565 41 51
Email: info@orfoundation.org

OR Foundation – U.S. Section

2300 Riverchase Center
Birmingham, AL 35244
USA
Phone: +1 205 986 7989
Email: info.us@orfoundation.org

Newsletter

  • Facebook
  • Twitter
  • RSS

© Oral Reconstruction Foundation 2023 | Imprint | Disclaimer | Privacy | Sitemap | Professional websites Basel